India's IOL gains on China nod for anti-inflammatory drug
** Shares of IOL Chemicals and Pharmaceuticals IOLC.NS up 4.4% to 68.38 rupees ** IOLC says China's Center for Drug Evaluation approves anti-inflammatory Ibuprofen ** More than 1 mln shares change hands, 1x of 30-day avg ** Stock cuts YTD loss to about 16% (Reporting by Ashish Chandra in Bengaluru) ((ashish.chandra@thomsonreuters.com (+91 7982114624))
Recent news on IOL Chemicals and Pharmaceuticals
See all newsBrief: Iol Chemicals And Pharmaceuticals Says European Directorate For Quality Of Medicines & Healthcare Grants Certificate For Fenofibrate–Process II
Brief: IOL Chemicals And Pharmaceuticals June-Quarter Consol Profit 644 Million Rupees
Brief: IOL Chemicals and Pharmaceuticals Gets Approval From NMPA, China For Clopidogrel Bisulfate API
Brief: IOL Chemicals And Pharmaceuticals Reports Minor Fire Incident In Unit-9B Minoxidil Manufacturing Unit On June 9
Brief: IOL Chemicals And Pharmaceuticals March-Quarter Consol Profit 531.6 Million Rupees